Coronavirus Update | India reports 12,899 fresh COVID-19 cases, 15 fatalities in last 24 hours

An increase of 4,366 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

PTI

June 19, 2022 / 10:59 IST

Representative image (Source: Reuters)

India on Sunday recorded 12,899 fresh COVID-19 cases that pushed its infection tally to 4,32,96,692, while the number of active cases increased to 72,474, according to Union health ministry data.

The death toll climbed to 5,24,855 with 15 fresh fatalities, the data updated at 8 am stated. The active cases comprise 0.17 per cent of the total infections. The national COVID-19 recovery rate was recorded at 98.62 per cent, the health ministry said. The active cases comprise 0.17 per cent of the total infections.

An increase of 4,366 cases has been recorded in the active COVID-19 caseload in a span of 24 hours. The daily positivity rate was recorded at 2.89 per cent and the weekly positivity rate at 2.50 per cent, the ministry said.

The number of people who have recuperated from the disease surged to 4,26,99,363. The case fatality rate stood at 1.21 per cent, it said. According to the ministry, 196.14 crore COVID-19 vaccine doses have been administered so far in the country under the nationwide inoculation drive.

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the 1-crore mark on December 19. India crossed the grim milestone of 2 crore on May 4, 3 crore on June 23 and 4 crore on January 25 this year.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Coronavirus Update | India reports 12,899 fresh COVID-19 cases, 15 fatalities in last 24 hours

An increase of 4,366 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

Related Stories

Subscribe to Tech Newsletters

Coronavirus Update | India reports 12,899 fresh COVID-19 cases, 15 fatalities in last 24 hours

An increase of 4,366 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

Related Stories

Subscribe to Tech Newsletters

Trending news